Trust Company of Vermont’s 2seventy bio TSVT Stock Holding History

Trust Company of Vermont’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83	Closed	-$410	–	1136
2025 Q1	$410	Hold	83	–	–	﹤0.01%	995
2024 Q4	$244	Hold	83	–	–	﹤0.01%	1023
2024 Q3	$392	Hold	83	–	–	﹤0.01%	1004
2024 Q2	$320	Hold	83	–	–	﹤0.01%	863
2024 Q1	$444	Buy	+83	New	+$390	﹤0.01%	818

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Trust Company of Vermont's TSVT Position: Q2 2025 in Review

Trust Company of Vermont sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 83 shares — an estimated $410 sold.

Trust Company of Vermont first reported a position in TSVT in Q1 2024 and held it in 5 quarters. The position peaked at $444 in Q1 2024. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Trust Company of Vermont reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Trust Company of Vermont sold 83 2seventy bio shares in Q2 2025, an estimated $410.
Trust Company of Vermont first reported a position in 2seventy bio in Q1 2024 and held it in 5 quarters.
Trust Company of Vermont's 2seventy bio position peaked at $444 in Q1 2024.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Trust Company of Vermont's 13F filing for Q2 2025, filed 18 Jul 2025.